Non-Cystic Fibrosis Bronchiectasis
Non-cystic fibrosis bronchiectasis is a lung condition where the airways become damaged and widened, leading to persistent cough, mucus production, and frequent lung infections.
Ensifentrine for Non-Cystic Fibrosis Bronchiectasis
We are studying whether nebulized ensifentrine can help reduce lung flare-ups in people with non-cystic fibrosis bronchiectasis. The trial also examines its impact on respiratory symptoms and overall quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 85 years old?
- Do you have a history of bronchiectasis (chronic cough, sputum production, or recurrent respiratory infections)?
- Are you currently producing sputum (mucus) regularly?
- Have you had at least one worsening of your lung condition that required antibiotics in the past year?
- Are you a current smoker?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ensifentrine
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
UO Pneumologia e Terapia Intensiva Respiratoria
Bologna, Italy
Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania
U.O.C Pneumologia
Canalicchio, Italy
Fondazione IRCCS Policlinico San Matteo
SC Pneumologia
Pavia, Italy
Sponsor: Verona Pharma PLC
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.